Literature DB >> 22619194

Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study.

Julia Hippisley-Cox1, Carol Coupland.   

Abstract

OBJECTIVE: To develop and validate an updated version of the QFracture algorithm for estimating the risk of a patient sustaining an osteoporotic fracture or hip fracture in a primary care population.
DESIGN: Prospective open cohort study using routinely collected data from 420 general practices in the United Kingdom to develop updated QFracture scores and 207 practices to validate scores. Cox's proportional hazards model was used in the derivation cohort to derive risk equations using several explanatory variables. We calculated measures of calibration and discrimination using the validation cohort. PARTICIPANTS: 3,142,673 patients in derivation cohort and 1,583,373 in validation cohort, aged 30-100 years, who contributed 23,608,337 and 11,732,106 person years of observation, respectively. We identified 59,772 incident diagnoses of osteoporotic fracture in the derivation cohort and 28,685 in the validation cohort. OUTCOMES: Incident diagnosis of osteoporotic fracture (vertebral, distal radius, proximal humerus, or hip) and incident hip fracture recorded in general practice records or linked cause of death records.
RESULTS: We found significant independent associations with overall fracture risk in women for age, body mass index, ethnic origin, alcohol intake, smoking status, chronic obstructive pulmonary disease or asthma, any cancer, cardiovascular disease, dementia, diagnosis or treatment for epilepsy, history of falls, chronic liver disease, Parkinson's disease, rheumatoid arthritis or systemic lupus erythematosus, chronic renal disease, type 1 diabetes, type 2 diabetes, previous fracture, endocrine disorders, gastrointestinal malabsorption, any antidepressants, corticosteroids, unopposed hormone replacement therapy, and parental history of osteoporosis. Risk factors for hip fracture in women were similar except for gastrointestinal malabsorption and parental history of hip fracture. Risk factors for men were largely the same as those for women but also included care home residence. The updated hip fracture algorithm explained 71.7% (95% confidence interval 71.1% to 72.3%) of the variation in women and 70.4% (69.3% to 71.5%) in men. D statistic values for hip fracture were high for women (3.26, 3.21 to 3.31) and men (3.15, 3.06 to 3.24), and higher than for osteoporotic fracture. Values for the area under the receiver operating characteristics curves for hip fracture were 0.89 for women and 0.88 for men, compared with 0.79 and 0.71 for osteoporotic fracture, respectively. The updated algorithms performed better than the 2009 algorithms.
CONCLUSIONS: Two QFracture algorithms were updated to predict risk of osteoporotic and hip fracture in primary care populations to include ethnic origin, all classes of antidepressants, chronic obstructive pulmonary disease, epilepsy, dementia, Parkinson's disease, cancer, systemic lupus erythematosus, chronic renal disease, type 1 diabetes, previous fragility fracture, and care home residence. These updated algorithms showed improved performance compared with previous QFracture algorithms reported in 2009.

Entities:  

Mesh:

Year:  2012        PMID: 22619194     DOI: 10.1136/bmj.e3427

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  106 in total

1.  Fall-related risk factors and heel quantitative ultrasound in the assessment of hip fracture risk: a 10-year follow-up of a nationally representative adult population sample.

Authors:  M Kauppi; S Stenholm; O Impivaara; J Mäki; M Heliövaara; A Jula
Journal:  Osteoporos Int       Date:  2014-06       Impact factor: 4.507

2.  Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry.

Authors:  William D Leslie; Helena Johansson; Eugene V McCloskey; Nicholas C Harvey; John A Kanis; Didier Hans
Journal:  J Bone Miner Res       Date:  2018-07-16       Impact factor: 6.741

3.  Fracture Risk Assessment in Long-term Care (FRAiL): Development and Validation of a Prediction Model.

Authors:  Sarah D Berry; Andrew R Zullo; Yoojin Lee; Vincent Mor; Kevin W McConeghy; Geetanjoli Banerjee; Ralph B D'Agostino; Lori Daiello; David Dosa; Douglas P Kiel
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-05-09       Impact factor: 6.053

4.  Alcohol consumption and hip fracture risk.

Authors:  X Zhang; Z Yu; M Yu; X Qu
Journal:  Osteoporos Int       Date:  2014-09-30       Impact factor: 4.507

Review 5.  Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  X Wang; S Yan; C Liu; Y Xu; L Wan; Y Wang; W Gao; S Meng; Y Liu; R Liu; D Xu
Journal:  Osteoporos Int       Date:  2016-01-11       Impact factor: 4.507

6.  [Identification, diagnostics and guideline conform therapy of osteoporosis (DVO) in trauma patients : a treatment algorithm].

Authors:  C Neuerburg; R Schmidmaier; S Schilling; C Kammerlander; W Böcker; W Mutschler; U Stumpf
Journal:  Unfallchirurg       Date:  2015-11       Impact factor: 1.000

7.  Is prophylactic anti-resorptive therapy required in thyroid cancer patients receiving TSH-suppressive treatment with thyroxine?

Authors:  Graham R Williams
Journal:  J Endocrinol Invest       Date:  2014-06-18       Impact factor: 4.256

8.  Fracture prediction from self-reported falls in routine clinical practice: a registry-based cohort study.

Authors:  W D Leslie; S N Morin; L M Lix; P Martineau; M Bryanton; E V McCloskey; H Johansson; N C Harvey; J A Kanis
Journal:  Osteoporos Int       Date:  2019-08-02       Impact factor: 4.507

Review 9.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

Review 10.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.